Biosplice logo_final RGB 300 dpi_white background.png
Biosplice Publishes Successful Clinical Trial in Knee Osteoarthritis
April 26, 2021 09:15 ET | Biosplice Therapeutics, Inc.
SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering therapeutics based on alternative pre-mRNA splicing for...
Syneos Health_rgb_r.jpg
Syneos Health Partners with Medable, Expanding Decentralized Solutions to Bring Clinical Trials Closer to the Patient
April 20, 2021 09:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C. and PALO ALTO, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and Medable, the leading...
Syneos Health_rgb_r.jpg
Syneos Health and Protocol First Partner to Accelerate Collection and Review of Clinical Trial Data
February 24, 2021 09:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C. and SALT LAKE CITY, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and Protocol First, Inc., a...
cmed-logo_no tagline_png.png
New app optimizes home visits for virtual clinical trials
May 06, 2020 03:00 ET | Cmed
HORSHAM, United Kingdom, May 06, 2020 (GLOBE NEWSWIRE) -- Cmed Technology announces the encapsia Home Visit app to capture and manage clinical trial data from patients at home or in the community....
LipoMedix.png
LipoMedix Announces Publication of Positive Phase 1 Data for Promitil® (PL-MLP) in Research Journal Investigational New Drugs
January 23, 2020 09:00 ET | LipoMedix
JERUSALEM, Jan. 23, 2020 (GLOBE NEWSWIRE) -- LipoMedix, a clinical-stage, oncology-focused pharmaceutical company, involved in the development of innovative, safe and effective cancer therapy based...
Rafael_Pharma-Logo+Slogan.png
Clinical Cancer Research Publishes Phase I Data from a Study of Rafael Pharmaceuticals' Lead CPI-613 Compound in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia
April 12, 2018 11:00 ET | Rafael Pharmaceutical Inc.
Newark, NJ, April 12, 2018 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced that data from the Phase I...